.svg){kind=icon}
In this episode of The Clinical Current, Leesa Gentry shares how RenovoRx is advancing innovation in interventional oncology while operating with a lean, highly focused clinical model. Drawing on decades of experience across pharma, biotech, and CRO environments, Leesa discusses what it really takes to run a Phase 3 program without a traditional global CRO, how COVID permanently reshaped site operations, and why technology and flexible leadership are now essential for trial execution. It’s a candid look at modern clinical operations in an era of tighter timelines, fewer resources, and higher expectations.
AI in clinical research isn’t just hype—it’s happening. But how can sponsors, CROs, and clinical teams integrate it strategically and responsibly without compromising compliance?
In this episode, Kelly Roland returns to The Clinical Current to go beyond the headlines and break down what today’s leaders should be paying attention to.
In this episode of The Clinical Current, we sit down with clinical quality operations expert Rachel Hoffmann Sund to talk all things change management, quality metrics, and what it really takes to embed continuous improvement in clinical research.
In the debut episode of The Clinical Current, host Teresa Hines welcomes guest Kelly Roland for a candid conversation about artificial intelligence in clinical research. Titled Molecules & Machines, this episode explores how AI is being integrated into drug development—from trial design to operational execution.
Together, they break down what’s real, what’s overpromised, and how sponsors can evaluate AI tools with clarity and confidence. Whether you’re exploring AI for the first time or navigating a crowded vendor landscape, this episode offers insights that help you cut through the noise and focus on what truly drives value.
Reach out to our dedicated team for any inquiries, appointment scheduling, or support.
